Articles
Page 24 of 24
-
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A67
-
Therapeutic potential of a novel multifunctional iron chelator on cognitive decicits and insulin degrading enzyme expression in a rat model of sporadic Alzheimer's disease
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A65 -
Pharmacochaperoning of the ER-retained A1adenosine receptor
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A63 -
Functional and physical interactions between P2Y receptors and ion channels
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A61 -
Identifying forces that stabilize the oligomeric state of bacterial homologs of neurotransmitter transporters
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A59 -
Deciphering structural rearrangements during transport process in the bacterial transporter GltPh, homolog to mammalian glutamate transporter
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A57 -
Calmodulin kinase II regulates amphetamine-induced reverse transport in dopamine and serotonin transporters
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A56 -
The effect of chronic fluoxetine administration on anxiety-like behavior and expression of 5-HT-related proteins in rats with constitutively altered 5-HT homeostasis
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A30 -
Understanding subtype-selective allosteric modulation of GABAAreceptors
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A26 -
The relaxation of non-pregnant rat myometrium by resveratrol with participation of the NO–cGMP pathway
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A24 -
Nitric oxide signaling in adipose triglyceride lipase-deficient microvascular endothelial cells
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A22 -
Use of ACE inhibitors in Serbia in 2010
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A3 -
Antidepressant-like effects of benzodiazepine site inverse agonists in the rat forced swim test
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A1 -
Validation of a transparent decision model to rate drug interactions
Multiple databases provide ratings of drug-drug interactions. The ratings are often based on different criteria and lack background information on the decision making process. User acceptance of rating systems...
Citation: BMC Pharmacology and Toxicology 2012 13:7 -
Tox-Database.net: a curated resource for data describing chemical triggered in vitro cardiac ion channels inhibition
Drugs safety issues are now recognized as being factors generating the most reasons for drug withdrawals at various levels of development and at the post-approval stage. Among them cardiotoxicity remains the m...
Citation: BMC Pharmacology and Toxicology 2012 13:6 -
Microneedle pretreatment enhances the percutaneous permeation of hydrophilic compounds with high melting points
Two commercially available microneedle rollers with a needle length of 200 μm and 300 μm were selected to examine the influence of microneedle pretreatment on the percutaneous permeation of four non-steroidal ...
Citation: BMC Pharmacology and Toxicology 2012 13:5 -
Exploring the relationship between safety culture and reported dispensing errors in a large sample of Swedish community pharmacies
The potential for unsafe acts to result in harm to patients is constant risks to be managed in any health care delivery system including pharmacies. The number of reported errors is influenced by a various ele...
Citation: BMC Pharmacology and Toxicology 2012 13:4 -
The potential for selective pharmacological therapies through biased receptor signaling
The discovery that not all agonists uniformly activate cellular signaling pathways (biased signaling) has greatly changed the drug discovery process for agonists and the strategy for treatment of disease with ...
Citation: BMC Pharmacology and Toxicology 2012 13:3 -
An interview with Philip Biggin, Section Editor for Computational, in silico and modelling studies
Citation: BMC Pharmacology and Toxicology 2012 13:2 -
Only connect: the merger of BMC Pharmacology and BMC Clinical Pharmacology
This editorial celebrates the launch of BMC Pharmacology and Toxicology within the BMC series of journals published by BioMed Central. The scope of the journal is interdisciplinary encompassing toxicology, experi...
Citation: BMC Pharmacology and Toxicology 2012 13:1
Annual Journal Metrics
-
2022 Citation Impact
2.9 - 2-year Impact Factor
2.9 - 5-year Impact Factor
0.932 - SNIP (Source Normalized Impact per Paper)
0.603 - SJR (SCImago Journal Rank)2022 Speed
26 days submission to first editorial decision for all manuscripts (Median)
198 days submission to accept (Median)2022 Usage
642,939 downloads
1,154 Altmetric mentions
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication